首页> 美国卫生研究院文献>Springer Open Choice >Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia in Rat Stomach
【2h】

Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia in Rat Stomach

机译:基于生理学的药代动力学和药效学建模可通过乙酰胆碱抑制乙酰胆碱酯酶(一种新的胃肠动力药物治疗功能性消化不良)抑制大鼠胃

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeAcotiamide, a gastroprokinetic agent used to treat functional dyspepsia, is transported to at least two compartments in rat stomach. However, the role of these stomach compartments in pharmacokinetics and pharmacodynamics of acotiamide remains unclear. Thus, the purpose of this study was to elucidate the relationship of the blood and stomach concentration of acotiamide with its inhibitory effect on acetylcholinesterase (AChE).
机译:目的将用于治疗功能性消化不良的胃肠动力药乙酰甲酰胺转运至大鼠胃中的至少两个隔室。然而,这些胃室在乙酰甲酰胺的药代动力学和药效学中的作用尚不清楚。因此,本研究的目的是阐明血和胃液中阿替酰胺的浓度与其对乙酰胆碱酯酶(AChE)的抑制作用之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号